CD8+ T cells and associated signaling pathways influence osteoclast formation and osteoblast differentiation in osteoporosis
Immune Cells and Signaling Pathways Influence Bone Health in Osteoporosis
This narrative review synthesizes the role of CD8+ T cells and related cytokines like IFN-gamma, CCL5, and IL-33 in bone metabolism. The aut…
New research highlights how specific immune cells and signaling pathways may play a dual role in protecting or promoting bone loss in osteop…
Novel osteoporosis therapies targeting osteoclast fusion and polarization show promise beyond bisphosphonates
New osteoporosis treatments target bone-eating cells more safely
This narrative review examines emerging therapeutic strategies that target osteoclast fusion and polarization, including DC-STAMP/OC-STAMP n…
Future osteoporosis drugs may work by blocking the fusion of bone-destroying cells, offering a safer alternative to current treatments.
Physical exercise therapy may support osteosarcopenia management in elderly patients according to this narrative review
Exercise may help fight bone and muscle loss in aging
This narrative review discusses physical exercise therapy for osteosarcopenia in the elderly population. The authors outline potential benef…
A new review suggests physical exercise could slow bone and muscle loss in older adults with osteosarcopenia.
Network meta-analysis reveals optimal aerobic exercise frequency and intensity for improving bone mineral density in osteoporosis patients
Network meta-analysis finds aerobic exercise improves bone density in osteoporosis patients
A comprehensive network meta-analysis of 2,183 participants demonstrates that aerobic exercise significantly boosts bone mineral density acr…
A network meta-analysis of 2,183 participants shows aerobic exercise improves bone density better than control, with specific intensity and …
Drug-induced osteoporosis mechanisms and gut microbiota links remain largely unresolved for most medication classes
Many common medicines might change gut bacteria and affect bone strength in older adults
This narrative review examines the association between medications such as glucocorticoids and aromatase inhibitors and gut microbiota alter…
Some drugs like antidepressants and seizure medicines can alter gut bacteria. Scientists are still studying if these changes hurt bones or c…
Gut microbiome metabolites regulate bone health via SCFAs, bile acids, and tryptophan pathways
Multi-omics approaches reveal new links between gut microbes and bone health
This narrative review synthesizes evidence that gut microbiome metabolites—SCFAs, bile acids, and tryptophan derivatives—regulate bone remod…
A narrative review suggests gut microbes may influence bone conditions like osteoporosis and osteoarthritis through specific metabolic pathw…
Narrative review on polysaccharide metabolites from kidney-tonifying TCM for osteoporosis
Chinese Medicine Compounds Show Promise for Osteoporosis
This narrative review synthesizes preclinical evidence on polysaccharide metabolites from kidney-tonifying traditional Chinese medicine for …
A review of kidney-tonifying Chinese medicine compounds suggests they may help treat osteoporosis, but human trials are needed.
Systematic review and meta-analysis of Salvia miltiorrhiza for osteoporosis in animal models
Lab tests show Salvia miltiorrhiza helps bones grow stronger in animal studies
This systematic review and meta-analysis of 24 animal studies found that Salvia miltiorrhiza-derived interventions significantly improved bo…
A review of twenty-four animal studies found that Salvia miltiorrhiza treatments significantly improved bone density and strength. These lab…
Narrative review on gut-bone axis biomaterials for osteoporosis therapy
New materials help treat bone loss by talking to the gut bacteria inside the body
This narrative review synthesizes theoretical guidance on gut microbiota modulation and functional biomaterials for osteoporosis. It highlig…
Scientists are testing special materials that can change gut bacteria to help heal weak bones. These new tools might stop bone loss and redu…
Narrative review examines Chinese botanical drugs for osteoporosis without reported clinical data
Chinese botanical drugs show promise for osteoporosis but evidence remains limited
This narrative review discusses the use of Chinese botanical drugs for osteoporosis. The authors note that key details such as population, s…
A review suggests Chinese botanical drugs may help with osteoporosis, though more research is needed to confirm their safety and effectivene…
Review of senescence-associated secretory phenotype in aging osteoarthritis and disc degeneration
Aging cells release signals that may worsen bone and joint disease in older adults
This narrative review examines the senescence-associated secretory phenotype (SASP) in aging populations with osteoarthritis, intervertebral…
A review suggests aging cell signals could drive bone and joint problems. This insight helps doctors understand why these conditions worsen …
Network meta-analysis compares osteoporosis drugs for bone density in men
Men's Osteoporosis Drugs Work Better on Spines Than Hips
This network meta-analysis of 4,409 men with primary osteoporosis compared six medications. It found significant improvements in bone minera…
• Abaloparatide and teriparatide boost spine bone density most • Helps men with weak bones avoid fractures • Not yet proven to prevent actua…
Questions about Osteoporosis
Can MRI scans and machine learning predict osteoporosis and abnormal bone density?
Yes, MRI scans combined with machine learning can predict osteoporosis and abnormal bone density with high accuracy, often matching or exceeding CT-based methods.
Full answer →Can VBQ scores and Hounsfield Units predict fractures after vertebral augmentation?
Yes, both VBQ scores and Hounsfield Units can predict fractures after vertebral augmentation, with VBQ showing slightly better sensitivity.
Full answer →Does romosozumab improve bone strength in postmenopausal women with osteoporosis?
Yes, romosozumab improves bone strength in postmenopausal women with osteoporosis, as shown by increases in shear bone strength, volumetric BMD, and trabecular bone score in clinical trials.
Full answer →All Osteoporosis Articles
- CD8+ T cells and associated signaling pathways influence osteoclast formation and osteoblast differentiation in osteoporosis
- Novel osteoporosis therapies targeting osteoclast fusion and polarization show promise beyond bisphosphonates
- Physical exercise therapy may support osteosarcopenia management in elderly patients according to this narrative review
- Network meta-analysis reveals optimal aerobic exercise frequency and intensity for improving bone mineral density in osteoporosis patients
- Drug-induced osteoporosis mechanisms and gut microbiota links remain largely unresolved for most medication classes
- Gut microbiome metabolites regulate bone health via SCFAs, bile acids, and tryptophan pathways
- Narrative review on polysaccharide metabolites from kidney-tonifying TCM for osteoporosis
- Systematic review and meta-analysis of Salvia miltiorrhiza for osteoporosis in animal models
- Narrative review on gut-bone axis biomaterials for osteoporosis therapy
- Narrative review examines Chinese botanical drugs for osteoporosis without reported clinical data
- Review of senescence-associated secretory phenotype in aging osteoarthritis and disc degeneration
- Network meta-analysis compares osteoporosis drugs for bone density in men
- Romosozumab improves shear bone strength in postmenopausal women with osteoporosis in BCT substudies
- VBQ and Hounsfield Units Predict Subsequent Fractures After Vertebral Augmentation
- Systematic Review and Meta-Analysis Links α-Klotho to Frailty and Bone Health in Aging
- Nomogram Predicts Osteoporosis Risk in Rheumatoid Arthritis Patients
- Machine learning radiomics on MRI sequences predicts osteoporosis and abnormal bone density in retrospective cohort
- Narrative review examines coronary risk and vascular effects of bisphosphonates, denosumab, and romosozumab in osteoporosis
- Narrative review explores gut metabolites postbiotics obesity fatty liver and bone loss associations
- Meta-analysis of preclinical studies supports kaempferol for osteoporosis
- L1 Cortical Bone Quantitative CT Parameters Show Association With Osteoporosis in 169 Patient Cohort
- Narrative review links gut dysbiosis and immune changes to osteoporosis mechanisms in postmenopausal women and older adults
- Higher Geriatric Nutritional Risk Index linked to lower osteoporosis risk in diabetic women
- Review examines current endocrine causes of secondary osteoporosis and clinical management approaches
- Narrative review discusses Erzhi Pill for osteoporosis and menopausal syndrome with noted limitations
- Machine learning model using 32 variables predicts osteoporotic fractures in postmenopausal women
- Narrative review explores engineered exosomes for bone disorders, notes translational challenges
- Meta-analysis links long-term glucocorticoid use and SLE duration to high osteoporosis prevalence in patients
- Systematic review of osteoporosis interventions reports mixed outcomes with no specific medication data provided
- PCKP reduces early pain and leakage versus UPKP in osteoporotic vertebral fractures
- Review of quercetin in metabolic diseases shows promise but lacks clinical validation
- Systematic review links gut microbiota dysbiosis to CKD-MBD, RA, OA, and OP pathogenesis
- In male osteoporosis, anabolic therapies improved lumbar spine and hip BMD more than antiresorptives at 12 months
- Systematic review examines angiogenesis-targeting strategies for osteoporosis and fracture healing
- Resistance training improves quality of life in older adults with osteoporosis, meta-analysis finds
- Denosumab showed no effect on periprosthetic bone density five years after uncemented total hip arthroplasty
- Retrospective study finds inverse association between NHHR and osteoporotic fracture risk